Oriola Oyj reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was EUR 375.1 million compared to EUR 360.4 million a year ago. Net loss was EUR 2.3 million compared to net income of EUR 1.1 million a year ago.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.932 EUR | +1.30% | -2.31% | -14.52% |
Apr. 30 | Sweden’s Competition Watchdog Prohibits Oriola's Dose Dispensing Unit Sale | MT |
Apr. 29 | ApotekstjÄNst Sverige Ab cancelled the acquisition of Svensk Dos AB. | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.52% | 189M | |
+20.04% | 72.24B | |
-2.10% | 24.04B | |
+7.33% | 8.92B | |
+10.34% | 8.58B | |
-19.68% | 8.07B | |
+14.35% | 5.24B | |
+14.69% | 4.24B | |
-1.04% | 4.15B | |
-2.47% | 3.92B |
- Stock Market
- Equities
- OKDBV Stock
- News Oriola Oyj
- Oriola Oyj Reports Earnings Results for the First Quarter Ended March 31, 2024